Expertise in
8
conditions

Gerald M. Liew

Sydney, NSW, AU 
Expertise in
8
conditions
Sydney, NSW, AU 

Overview

Gerald Liew practices practicing medicine in Sydney, Australia.

Mr. Liew is highly rated in 8 conditions, according to our data. His clinical expertise encompasses Diabetic Retinopathy, Age-Related Macular Degeneration (ARMD), Late-Onset Retinal Degeneration, Diabetic Macular Edema (DME), and Vitrectomy.

He is actively involved in clinical research, co-authoring 162 peer reviewed articles and participating in 2 clinical trials.

Gender

Male

Locations

Sydney, NSW, Australia
Other Locations
Liverpool, NSW, Australia
Westmead, NSW, Australia
Camperdown, NSW, Australia
Camperdown, VIC, Australia

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

A Randomised Trial to Evaluate the Efficacy on Retinopathy and Safety of Fenofibrate in Adults With Type 1 Diabetes. A Multicentre Double-blind Placebo-controlled Study in Australia and Internationally.
A Randomised Trial to Evaluate the Efficacy on Retinopathy and Safety of Fenofibrate in Adults With Type 1 Diabetes. A Multicentre Double-blind Placebo-controlled Study in Australia and Internationally.
Enrollment Status: Active_not_recruiting
Publish Date: January 20, 2026
Intervention Type: Drug
Study Drug: Fenofibrate
Study Phase: Phase 3
A Randomised, Double-Masked Vehicle-Controlled, Multiple Dose, Dose Escalation Study To Evaluate The Safety and Tolerability of EXN407 in Subjects With Centre Involved Diabetic Macular Oedema Secondary to Diabetes Mellitus
A Randomised, Double-Masked Vehicle-Controlled, Multiple Dose, Dose Escalation Study To Evaluate The Safety and Tolerability of EXN407 in Subjects With Centre Involved Diabetic Macular Oedema Secondary to Diabetes Mellitus
Enrollment Status: Completed
Publish Date: May 09, 2025
Intervention Type: Drug
Study Drug: EXN407
Study Phase: Phase 1/Phase 2
View 1 Less Clinical Trial

162 Total Publications

Light- and X-ray-Activated Liposomes for Controlled Gene Editing and Drug Delivery.
Light- and X-ray-Activated Liposomes for Controlled Gene Editing and Drug Delivery.
Journal: Journal of visualized experiments : JoVE
Published: August 18, 2026

Frequently Asked Questions about Gerald M. Liew

Is Gerald M. Liew a top-rated expert for Diabetic Retinopathy?

MediFind is an objective health platform that identifies experts based on real-world data. Gerald M. Liew is classified as an Distinguished expert for Diabetic Retinopathy, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Gerald M. Liew participate in research or clinical trials?

Yes. Gerald M. Liew has published 162 articles and abstracts on conditions like Diabetic Retinopathy. You can view a list of Gerald M. Liew's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Liew's expertise for a condition
ConditionClose
    View All 17 Experienced Conditions
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile